ABSTRACT
Advances in additive manufacturing (AM) in endless fields of application have come about in the last three decades. The application of 3D printers for the production of customised pharmaceutical products and manufacture of personalised medicine enables stability and release profiles of multiple drugs. AM aims to exhibit the future of technology by manufacturing tailored products as a one-stop solution. A recent rise in multiple diseases is reflected in a sharp increase in surgical procedures of internal organs and tissues, and AM technology helps surgeons to preplan the surgery with the help of 3D models. AM printing is going to transform everything which has a huge impact on human lives and indirectly on the whole globe. So we should be ready to handle these technologies like double-edged swords. The alternative to this major issue is to use individual patients’ body cells to develop the proper tissue or organ which minimises the peril of rejection by using AM technology. Thereby, the need for immunosuppressants would be substantially reduced.
